Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma
2021 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma
Straka, C.; Salwender, H.; Knop, S.; Vogel, M.; Müller, J. ; Metzner, B. & Langer, C. et al. (2021)
European Journal of Haematology, art. ejh.13690. DOI: https://doi.org/10.1111/ejh.13690
